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Abstract 
The synthetic versatility of PYA ligands has been exploited to prepare and evaluate a diverging 
series of iridium complexes containing C,N-bidentate chelating aryl-PYA ligands for water 
oxidation catalysis. The phenyl-PYA lead structure 1 was modified (i) electronically through 
introduction of one, two, or three electron-donating methoxy substituents on the aryl ring, (ii) 
by incorporating long aliphatic chains to the pyridyl fragment of the PYA unit, and (iii) by 
altering the PYA positions from para-PYA to its ortho- and meta-isomers. Electrochemistry 
indicated no substantial electronic effect of the aliphatic chains, and only minor changes of the 
electron density at iridium when modifying the aryl ligand site, yet substantial alteration if the 
PYA ligand is the ortho- (E1/2 = +0.72 V), para- (E1/2 = +0.64 V) or meta-isomer (E1/2 = +0.56 
V vs SCE). In water oxidation catalysis, the long alkyl chains did not induce any rate 
enhancement compared to the phenyl-PYA lead compound, while MeO groups incorporated in 
the aryl group enhanced catalytic activity from a TOFmax =1600 h–1 in the original Ph-PYA 
system gradually as more MeO groups were introduced up to a TOFmax = 3300 h–1 for a 
tris(MeO)-substituted aryl-PYA system. The variation of the PYA substitution had only a minor 
impact on catalytic activity and revealed only a weak trend in the sequence ortho > meta > 
para. The high activity of the tris(MeO) system and the ortho-PYA isomer were attributed to 
efficient hydrogen bonding that assists O–H bond activation and proton transfer. Remarkably 
merging of the two optimized motifs, i.e. an aryl unit with three OMe substituents and the PYA 
as ortho isomer, into a single new aryl-PYA ligand system failed to improve catalytic activity. 
Computational analysis suggests too much congestion at the active site, which hinders catalytic 
turnover. These results illustrate the complexity of ligand design and the subtle effects at play 
in water oxidation catalysis. 
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Introduction 
Artificial photosynthesis entailing catalytic water splitting is one of the most promising 
processes to harness and store solar and other renewable energy.1,2 In pursuit of developing 
efficient water splitting systems, the water oxidation half-cycle has been demonstrated to be a 
severe limitation. Hurdles include, inter alia, the highly uphill thermodynamics of water 
oxidation, and as well as the complexity and kinetic barriers associated with the transfer of four 
protons and four electrons that is required for the formation of O2.3 In order to mediate the 
multiple transfer of electrons and to overcome the energetic barrier of O–H bond cleavage and 
O–O bond formation, a high redox-flexibility of the catalytic metal center is required.4 Initial 
approaches have been inspired by the natural oxygen evolving complex,5 focusing on di- and 
tetrametallic systems for chemically driven molecular water oxidation.6,7 More recently, one of 
us demonstrated that a single iridium center is active in water oxidation when bound to two 
phenylpyridyl ligands (A, Figure 1).8 While this work triggered investigations towards single 
site metal catalysts with other transition metals,9 including first row transition metal systems,10 
the activity of iridium complexes remained a benchmark.11,12 The use of stronger donor ligands 
like Cp* (C5Me5–) further enhanced catalytic activity (B),13 and even though strong support is 
available for a gradual oxidation of the Cp* unit under catalytic conditions,14 the [Ir(Cp*)] has 
emerged as a privileged synthon for designing water oxidation catalysts.11 In particular the 
introduction of chelating spectator ligands based on strong σ-donors like N-heterocyclic 
carbenes (NHCs) led to robust molecular catalysts with high activity (C).15,16 Recently, we have 
introduced pyridylideneamides (PYAs) as strong donor ligands17 to the [Ir(Cp*)] iridium 
complex 1 (Figure 1).18 This complex shows excellent performance in water oxidation catalysis, 
providing maximum turnover frequencies (TOFmax) of 1,600 h–1 and up to 86,000 turnovers. 
This high activity might be attributed to the considerable donor flexibility of the PYA ligand, 
and the ensuing stabilization of different metal oxidation states during the catalytic process (cf 
limiting resonance structures A and B for 1 in Figure 1). 
Here we have capitalized on the synthetic versatility of the phenyl-PYA ligand to optimize the 
lead iridium catalyst further. Based on recent studies, which showed a substantial rate 
enhancement by simple alterations on key positions of the ligands,19,20 we have exploited such 
modifications for enhancing the catalytic activity of complex 1 by modulating specifically i) 
the donor properties of the Ph ligand, ii) the N-substituent on the PYA ligand, and iii) the donor 
properties of the PYA ligand. 
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Figure 1. Iridium catalysts for water oxidation catalysis and limiting resonance structures of iridium PYA 
complex 1. 
 
Results and discussion 
Synthesis of complexes. i) Variation of donor properties of the Ph unit: We have 
recently described synthetic protocols for the introduction of methoxy groups on the phenyl 
ring of the parent complex 1.18 The preparation of these ligands was conveniently achieved due 
to the availability of the corresponding methoxy-substituted benzoic acids, which were readily 
transformed to the PYA ligands by reaction with 4-aminopyridine, pyridine alkylation and 
amide deprotonation. Metalation with [Ir(Cp*)Cl2]2 afforded the cyclometalated complexes 2–
5 (Figure 2), which exhibited enhanced catalytic activity in transfer hydrogenation of ketones 
and imines, as well as in alkyne hydrosilylation.19 The better catalytic performance relative to 
complex 1 was attributed to the higher electron density at the active site and the ensuing 
stabilization of higher oxidation states during the catalytic cycle. In an effort to quantify 
electronic impact of the different aryl-PYA ligands, we have now performed electrochemical 
analysis. Cyclic voltammetry (CV) in CH2Cl2 solution revealed a fully reversible oxidation 
wave that was assigned to an IrIII/IV oxidation process (Figure S1). For complex 1 without any 
substituent at the phenyl unit, this oxidation is centered at E1/2 = +0.64 V vs SCE (SCE = 
saturated calomel electrode), while methoxy-substituents shift the oxidation to lower potential, 
as expected for electron-donating groups. The half-wave potentials were shifted non-linearly to 
E1/2 = +0.61 V and +0.62 V for 2 and 3, respectively (both with one MeO group), and to lower 
potential, E1/2 = +0.58 V for complex 4 with two MeO substituents. However, complex 5 with 
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three MeO units was oxidized at higher potential, E1/2 = +0.61 V. While this data helps to 
rationalize the lower performance of complex 1 in transfer hydrogenation, it is remarkable that 
the substituent effect is not additive. The lowest oxidation potential was measured for complex 
4 with two MeO groups, which was also the most active transfer hydrogenation catalyst. In 
contrast, a third MeO group in complex 5 increases the potential again slightly, yet the catalytic 
activity is radically changed and the complex is essentially inactive. The small differences 
between the oxidation potentials of all complexes 1–5 suggests another limiting effect to reach 
the +IV oxidation state of the iridium center, especially once the first methoxy substituent is 
introduced, such as enhanced inductive effects of the oxo substituents, or steric factors imparted 
by the MeO substituents. 
 
 
Figure 2. Iridium complexes 2–5 bearing methoxy-substituted PYA ligands. 
 
ii) Modulating the N-substituent on the PYA ligand: Variation of the N-substituent on 
the PYA unit was motivated by work using triazolylidene iridium complexes for water 
oxidation.20 In that work, a ten-fold rate enhancement was observed when substituting a methyl 
substituent at the triazolylidene heterocycle by an octyl group, which was tentatively attributed 
to a specific aggregation processes induced by the long aliphatic chain. Based on these data, 
the pyridyl-bound methyl group of the PYA ligand in complex 1 was substituted with alkyl 
groups of different length. To this end, N-(pyridin-4-yl)benzamide was alkylated with 2-
iodopropane, 1-iodobutane and 1-iodooctane to yield the corresponding pyridinium salts 6a–c 
in excellent yields (91–95%, Scheme 1). Selective alkylation was unambiguously confirmed by 
HR-MS analysis, which displayed the expected [M–I]+ mass ion for the isopropyl, butyl and 
octyl salts at 241.1329, 255.1489 and 311.2111 amu, respectively (theoretical values 241.1341, 
255.1492 and 311.2118 amu, respectively) and by 1H NMR spectroscopy, which showed the 
appearance of a new set of resonances corresponding to the new NCH at dH = 4.88 (6a), and 
for the NCH2 unit at dH = 4.47 (6b) and 4.44 (6c), together with the expected resonances in the 
aliphatic region of the spectrum. The reaction of 6a–c with aqueous NaOH afforded the free 
ligands 7a–c in good yields (73–84%). The 1H NMR spectra of the free pyridylidene amides 
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indicated the disappearance of the amide proton around 8 ppm, as well as a significant upfield 
shift of almost a full ppm for the heterocyclic proton resonances, which is in agreement with 
previous studies and the relevance of the diene-type resonance structure.21 In contrast, the aryl 
proton signals were barely affected, indicating that only the pyridylidene system is involved in 
stabilizing the deprotonated amide, but not the aryl unit.  
 
 
Scheme 1. Synthesis of IrCp*PYA-type complexes 8a–c with different alkyl chains. 
 
Metalation was performed by reacting the free ligand with [Ir(Cp*)Cl2]2 in the presence of 
NaOAc as base,22 which induced cyclometalation and afforded the iridium complexes 8a–c in 
good yields (54–75%; Scheme 1). These complexes are air-stable and were purified by standard 
silica column chromatography without any precaution. Cyclometalation was demonstrated for 
all the complexes by the loss of one proton signal in the aromatic region of the 1H NMR 
spectrum. The structures of complex 8b and 8c were unequivocally confirmed by single crystal 
X-ray diffraction analysis (Figure 3). The molecular structures are unsurprising and bond 
lengths and angles around the iridium center are identical within standard deviations for both 
complexes and similar to related complexes (Table 1).19 The pyridyl Cα–Cβ bonds are 
consistently shorter (average 1.35 Å) compared to the Cβ–Cγ bonds (1.41 Å), confirming 
substantial contribution of the neutral diene-type resonance structure in the solid state, in 
agreement with previous studies (see Table S1).19,20,23  
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Figure 3. ORTEP diagram of 8b and 8c. (50% probability; hydrogen atoms and co-crystallised solvent molecules 
omitted for clarity, only one of the two independent molecules of 8b,c in the unit cell shown). Selected bond 
lengths (Å) and angles (°) for 8b: Ir–CPh 2.008(11), Ir– NPYA 2.127(9), Ir–Cl 2.409(3), Ir–Cp(centroid) 1.823(5), 
CPh–Ir–NPYA 77.4(4); dihedral angle C(O)–NPYA–Cg–Cb 24.5(11); for 8c: Ir–CPh 2.040(5), Ir–NPYA 2.121(4), Ir–Cl 
2.4161(14), Ir–Cp(centroid) 1.820(2), CPh–Ir–NPYA 77.5(2); dihedral angle C(O)–NPYA–Cg–Cb 29.1(8). 
 
Electrochemical analysis of complexes 8a–c by CV in CH2Cl2 revealed a fully reversible 
oxidation at E1/2 = +0.64 V vs SCE for all complexes 8a–c, which is identical to the potential 
measured for complex 1. This identical oxidation potential indicates that modulation of the N-
bound alkyl group has no significant influence on the donor properties of the PYA ligand, nor 
on the electronic configuration at the iridium center. 
 
iii) Modulation of the PYA donor properties: Modification of the donor properties of the PYA 
unit was anticipated to be effective by changing the position of the amide unit. While complex 
1 may be considered as a para-PYA unit with the amide in para position of the pyridyl nitrogen, 
derivatives with the amide in meta or ortho substitution will have considerably different 
electronic properties. An ortho-PYA system will feature a neutral limiting resonance 
structure,24 though the proximity of the N-methyl group and the amide C=O unit is expected to 
induce a dihedral strain (Scheme 2A). In contrast, the meta-PYA unit lacks a neutral resonance 
form and therefore represents a unique mesoionic N-donor system (Scheme 2B), as detailed in 
a previous communication.25 Based on these considerations, variation of the substitution pattern 
was expected to have a pronounced effect on the donor properties. 
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Scheme 2. Limiting resonance structures of a generic ortho PYA complex (A, note also the steric constraint of the 
N–CH3 group with either the C=O or the ligands at the metal); and some of the relevant resonance structures of a 
generic meta PYA complex (B). 
 
The synthesis of the iridium complexes analogous to 1 but with meta- and ortho-PYA units was 
straightforward and started from benzoyl chloride, which was coupled with 2- or 3-
aminopyridine to form the amides 9a and 9b, respectively (Scheme 3).26 Subsequent 
methylation using MeI formed the meta pyridinium 10b in excellent yield (95%), while 10a 
was obtained only in a moderate 39% yield. This fact might be due to the lower nucleophilicity 
of the pyridine nitrogen or because of entropic effects associated with steric rigidity. Both salts 
showed the characteristic [M–I]+ ion in the HR-MS at 539.1684 and 539.1665 (theoretical value 
539.1669 amu). Alkylation was also supported by 1H NMR spectroscopy, in particular by the 
appearance of a new singlet for the N–CH3 group (4.29 and 4.41 ppm for 10a and 10b, 
respectively) as well as a downfield shift of the pyridinium proton signals when compared to 
the resonances of the pyridine precursors. Due to the lack of symmetry in the heterocycle, both 
pyridinium systems feature four distinct CH groups both in the 1H and 13C NMR spectra. Amide 
deprotonation was accomplished with NaOH and afforded the free ligands 11a,b as yellowish 
oils in good yields (~70%). The 1H NMR spectra of the free bases revealed the same 
characteristic signals as those described for the para-PYA 7, viz. disappearance of the amide 
proton as well as a 0.3–1.1 ppm upfield shift of the resonance frequencies of the heterocyclic 
protons.21  
The reaction of the free ligands with [Ir(Cp*)Cl2]2 in the presence of NaOAc induced 
cyclometalation and yielded, after purification by column chromatography, the iridium 
complexes 12a and 12b in good yields (~70%) as orange air-stable solids (Scheme 2). 1H NMR 
spectroscopy confirmed cyclometalation for both complexes by the loss of one proton signal in 
the aromatic region. Four distinct signals were present each for the pyridylidene unit as well as 
for the cyclometalated aryl ring.  
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Scheme 3. Synthesis of iridium complexes 12a and 12b. i) PhCOCl, NEt3; ii) MeI; iii) NaOH; iv) [Ir(Cp*)Cl2]2, 
NaOAc. 
 
The molecular structure of complex 12b with a mesoionic PYA ligand was further 
investigated by single crystal X-ray diffraction analysis. The complex reveals the classical 
three-legged piano-stool geometry with a pseudo-tetrahedral iridium center (Figure 4). Bond 
lengths and angles around the iridium center are similar to those of the related iridium 
complexes 1–5,18,19 and 8 (vide supra). However, the C–C and N–C bonds of the pyridylidene 
unit do not show any bond length alteration pattern, supporting the low relevance of a diene-
type structure with localized double bonds as noted for the para-PYA free ligands and 
complexes 1–5. All C–C bond length distances are equivalent within standard deviation and 
indicate high double bond conjugation as expected for an aromatic pyridyl ring.  
 
 
Figure 4. ORTEP diagram of iridium complex 12b (thermal ellipsoids at the 50% probability level; hydrogen 
atoms, co-crystallized solvent molecules, and second independent molecule of the unit cell omitted for clarity). 
Selected bond lengths (Å): Ir–C1 2.035(3), Ir–N1 2.103(2), Ir–Cl 2.4219(8), Ir–Cp(centroid) 1.819(2), C8–C9 
1.399(4), C8–C12 1.401(4), C9–C10 1.385(4), C10–C11 1.381(5). Selected bond angles (deg): C1–Ir–N1 
77.83(11), C1–Ir–Cl 86.42(8), N1–Ir–Cl 87.89(7); dihedral angle C(O)–N1–C8–C9 39.0(3). 	
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The donor properties were evaluated by electrochemical analysis. CV in CH2Cl2 
revealed a fully reversible oxidation process at E1/2 = +0.72 (vs SCE) for the ortho-PYA 
complex 12a and at +0.56 V (vs SCE) for complex 12b with a meta-PYA ligand (Figure 5). 
These potentials diverge considerably from the +0.64 V measured for the parent para-PYA 
complex 1 and indicate that the mesoionic PYA ligand 11b is a substantially stronger donor 
than para-PYA. Such stronger donor ability is expected when considering that p-acidic imine-
type bonding of the PYA ligand is disfavored in the mesoionic meta-PYA ligand, but much less 
in the para-PYA isomer. The significantly higher oxidation potential of complex 12a is 
remarkable and suggests that the ortho-PYA ligand is much less suitable for stabilizing higher 
metal oxidation states. The 80 mV potential difference between the para- and ortho-PYA is 
substantial, and presumably does not originate from simple resonance structure effects, but may 
relate to out of plane distortion of the PYA ligand instead.  
 
	
Figure 5. Superimposed CV plots of complexes 1 (black), 12a (blue) and 12b (red) in CH2Cl2 solution (0.1 M 
Bu4NPF6 as supporting electrolyte, 100 mV s–1 scan rate, potential vs SCE. 
 
Catalytic water oxidation. The structurally modified iridium complexes 2–5, 8a,b,c, and 
12a,b as well as the non-substituted parent complex 1 were investigated for catalytic water 
oxidation. The processes were chemically driven by (NH4)2[Ce(NO3)6] (CAN), a one-electron 
oxidant unable to oxidize water without a catalyst (Figure 6). All Ir(III) complexes were soluble 
in water (solubility at least 1 mg mL–1), and in the presence of CAN dissolved with 1M HNO3, 
immediate gas formation was observed and quantified dynamically with the homebuilt pressure 
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transducer setup.8 Complexes 8b and 8c have limited solubility in water due to the attached 
long alkyl chains (nBu and Oct respectively), and thus their concentrations used in the water 
oxidation experiments did not exceed 20 µM, while all the other complexes were tested at 
concentrations up to 50 µM. Stability tests in 0.1 M HNO3 (pH 2), and in the presence of 4 
molequiv. CAN did not indicate any complex degradation, nor loss of the MeO substituents 
(Fig. S2).27 Quantitative analysis of the oxygen evolution revealed higher or equivalent activity 
of complexes 2–5, 8, and 12 in comparison to the parent complex 1 (Table 2, entries 1–5). 
Methoxy substituents accelerated the catalytic rates: mono-substituted complexes 2 and 3 
displayed TOFs of 2400 h–1 and 1800 h–1 respectively (entries 6–11), while di-substituted 
complex 4 (entries 12–14) and tri-substituted complex 5 (entries 15–17) proved to be the most 
active catalysts exhibiting TOFs that exceeded 3000 h–1. As for the transfer hydrogenation 
catalysis, the incorporation of electron-donating groups enhances the catalytic activity in the 
water oxidation reaction, an effect that culminated with complexes 4 and 5, two of the most 
active iridium catalyst reported to date.28 These rate differences are considerable, and 
interestingly they are not correlated with the electrochemical measurements. Obviously higher 
oxidation states than the +IV species will need to be reached in a catalytic cycle and the 
electrochemically measured IrIII/IV redox potentials are therefore not correlated to turnover-
limiting processes. Though it is worth noting that there is no extrapolation from these potentials 
to the critical step of the catalytic cycle.29 
 
 
 
Figure 6. Oxygen evolution traces of the initial 11 h of water oxidation catalyzed by complex 1 at different 
concentrations (4.5-49.6 µM; for accurate concentrations of the complex, see Table 1). Solid lines represent the 
average of multiple measurements. Faded areas illustrate error bands at 95 % confidence interval.  
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Complexes 8a–c with different alkyl groups attached the pyridyl nitrogen all display about the 
same TOF as observed with complex 1 (~1500 h-1 at ~50 µM and ~1100 h-1 at ~20 µM; entries 
18–25). These results suggest that self-aggregation—as hypothesized in previous studies20—is 
not a key issue in this catalytic process, and that the presence of long alkyl chains in the 
triazolylidene system may therefore have different effects.30  
 
 
Table 1. Catalytic water oxidation with complex 1–5, 8a–c and 12a,b.a 
Entry Complex conc. [µM] CAN/complex TON TOFmax (h–1) 
1 1 49.6 7380 1,880 ± 30 1,600 ± 500 
2 1 19.9 20200 4,670 ± 90 1,200 ± 200 
3 1 9.9 40380 9,700 ± 200 840 ± 20 
4 1 4.5 80580 19,000 ± 1000 560 ± 60 
5 1 0.9 406510 86,000 ± 1000 160 ± 10 
6 2 50.1 7300 1,920 ± 30 2,400 ± 500 
7 2 19.9 18450 4,730 ± 90 1,600 ± 200 
8 2 4.5 81180 19,000 ± 400 600 ± 100 
9 3 49.1 7450 1,920 ± 30 1,800 ± 400 
10 3 19.6 18730 4,900 ± 100 1,400 ± 200 
11 3 4.5 81180 20,000 ± 400 700 ± 100 
12 4 49.7 7370 1,870 ± 20 3,300 ± 700 
13 4 19.8 18520 4,770 ± 50 1,500 ± 200 
14 4 4.6 79870 19,000 ± 300 700 ± 100 
15 5 50.1 7300 1,900 ± 30 3,200 ± 700 
16 5 20.3 18090 4,680 ± 50 1,600 ± 100 
17 5 4.6 79910 19,000 ± 300 650 ± 90 
18 8a 50.4 7240 1,840 ± 20 1,500 ± 300 
19 8a 0.9 406510 79,000 ± 1000 130 ± 10 
20 8b 19.8 20250 4,910 ± 80 1,100 ± 100 
21 8b 9.9 40500 10,000 ± 300 900 ± 200 
22 8b 4.9 80990 17,800 ± 400 500 ± 100 
23 8c 20.2 19820 5000 ± 90 1,100 ± 100 
24 8c 10.1 39640 9,600 ± 200 800 ± 100 
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25 8c 5.1 79270 18,200 ± 400 540 ± 80 
26 12a 49.9 7360 1,850 ± 30 1,800 ± 300 
27 12a 19.6 18790 4,700 ± 100 1,400 ± 300 
28 12a 9.8 37380 9,300 ± 100 1,000 ± 200 
29 12a 4.9 74750 17,500 ± 100 700 ± 200 
30 12b 49.9 7360 1,860 ± 20 1,700 ± 400 
31 12b 19.6 18790 4,640 ± 90 1,300 ± 200 
32 12b 9.8 37380 9,100 ± 200 700 ± 300 
33 12b 4.9 74750 17,400 ± 400 500 ± 300 
aMeasurements were performed in a sealed 40 mL EPA vial containing 10 mL 0.4M CAN solution buffered in 
1M HNO3 and the appropriate complex. O2 evolution was dynamically monitored with digital manometry and end 
points were calibrated by gas chromatography; TOFmax values were determined by calculating the rate of change 
of the generated oxygen over time from the kinetic trace.  	
The water oxidation catalytic activity of the regioisomers 12a and 12b of the parent 
para-PYA complex 1 was also evaluated (Table 2). Complex 12b with a mesoionic PYA ligand 
displayed water oxidation activity similar to that of the 4-substituted complex 1, reaching TOF 
of ~1700 h–1 (entries 30–33). This activity enhancement is marginal at best, despite the presence 
of a more electron-donating mesoionic ligand, which was expected to stabilize higher oxidation 
states better than the ortho- and para-PYA ligands (cf electrochemistry above). Surprisingly, 
complex 12a bearing a lower donor strength ligand than analogues 1 and 12b shows about the 
same performance as the other two regioisomers and achieves TOFs up to 1800 h–1 (entries 26–
29). Obviously, catalytic activity is not controlled solely by the donor strength of the ligand, 
but also by other factors such as steric influences that affect the (de)stabilization of the metal-
bound water or hydroxide intermediates during the catalytic reaction.  
DFT modeling was used to rationalize the structure-activity relationship observed for 
these catalysts. A geometry optimization (B3LYP/LANL2DZ) indicated why compounds 4 and 
5 were outperforming the other catalysts: the oxygen lone-pair of the methoxy group is in close 
proximity to the aqua ligand and forms a strong hydrogen bond (Figure 7a). This arrangement 
facilitates the deprotonation of this aqua site, especially as oxidation of the Ir(III) center 
increases the acidity of the linked proton dramatically.16c,31 Such hydrogen bonding and transfer 
can be repeated for the second proton after the iridium center is further oxidized to the IrIV–OH 
species, a process which constitutes a pathway for efficient proton-coupled electron transfer 
(PCET) and therefore results in a low-energy pathway towards a very reactive oxo-complex. 
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The PCET processes have been found to accelerate water oxidation in biological systems as 
well as in artificial electrochemically or chemically driven processes.32 
The smaller rate increase observed with complexes 12a and 12b is less obvious from 
the DFT structures. A hydrogen bond between the carbonyl group and the methyl group forming 
the pyridinium moiety stabilizes the ligand and induces a significant dihedral angle between 
the pyridylidene heterocycle and the phenylamide portion of the ligand (q = 53°), which 
weakens the electronic conjugation and lowers the relevance of the diene-type resonance 
structure (Figure 7b). It is important to note that the increase in reactivity imparted by this twist 
due to steric crowding is less notable than that caused by the direct link formed by the hydrogen 
bond between the methoxy group and the aqua ligand in 4 and 5. 
 
 
 
 
 
 
 
 
 
 
Figure 7. Hydrogen bonds lead to faster water oxidation: a) The methoxy group attached to the carbon adjacent 
to the cyclometalating site in complexes 4 and 5 is optimally positioned for accepting the proton from the aquo 
(and likewise hydroxyl) ligand upon oxidation of the iridium center; b) A weak hydrogen bond between the PYA 
N–CH3 and the amide CO group stabilizes the ortho-PYA ligand in 12a at a bigger dihedral angle (53°), which 
increases its donor strength compared to the considerably flatter para-substituted parent compound 1.  
 	
Catalyst optimization. While the introduction of long aliphatic chains had no effect on catalyst 
activity, modulation of the donor properties of both the phenyl group (by introducing electron-
donating methoxy substituents) and the PYA residues (by introducing mesoionic meta-PYA or 
sterically constrained ortho-PYA motifs) led to more active water oxidation catalysts. Merging 
these two leading catalyst design strategies was therefore a clear path to further improve the 
performance of the catalyst. The synthesis and characterization of the mesoionic target complex 
16b has been communicated recently.25 The analogue featuring an ortho-PYA ligand was 
prepared along the same route starting from the trimethoxy-substituted benzoyl chloride and 2-
aminopyridine to form the amide 13, followed by selective pyridine methylation with MeI to 
5 512b2a
A) B) 
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form the corresponding pyridinium salt 14 (Scheme 4). Deprotonated of the amide with aqueous 
NaOH afford the free PYA ligand as air-stable solid. The structure of the mesoionic PYA 15b 
has been reported as the first example of a mesoionic N-donor ligand.25 Complexation to 
iridium and cyclometalation was performed as described above in the presence of NaOAc and 
yielded the iridium complexes 16a,b in good yields (69–77%). Both complexes were fully 
characterized by NMR spectroscopy and HR-MS. In addition, single crystals of iridium 
complex 16a were obtained and analyzed by X-ray diffraction (Figure 8). The overall molecular 
geometry as well as bond lengths and angles around the iridium center are similar to the other 
structures reported here. Specifically, contribution of the diene-type resonance form of the 
ortho-PYA unit was noted by the bond length alteration in the heterocycle. The C8–C9 and 
C10–C11 bond lengths are 1.391(5) Å and 1.397(6) Å, respectively, and slightly longer than 
the C9–C10 and C11–C12 bonds (1.374(5) and 1.353(6) Å, respectively). These differences are 
smaller than in the para-PYA ligand of complexes 1–5, and 8a–c, but distinct from the 
mesoionic and fully conjugated meta-PYA system in complex 12b (cf Figure 4). Moreover, the 
pyridylidene heterocycle is significantly twisted out of the phenylamide plane, as indicated by 
the C7–N2–C8–N1 torsion angle q = –60.40(4)°. This value is close to the 53° predicted by 
DFT for these ortho-PYA iridium complexes (cf Figure 7b) and hence validate the steric 
argument suggested for the rate enhancement observed for complex 12a. Moreover, the 
distance between the N–CH3 proton and the amide oxygen atom is 2.337(2) Å, very similar to 
the 2.22 Å predicted by DFT calculations.  
 
Scheme 4.	 Synthesis of iridium complexes 16a and 16b. i) 2- or 3-aminopyridine, NEt3, MeI. ii) NaOH. iii) 
[Ir(Cp*)Cl2]2, NaOAc. 
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Figure 8. ORTEP diagram of iridium complex 16a. Thermal ellipsoids are given at the 50% probability level; 
hydrogen atoms and co-crystallized solvent molecules are omitted for clarity. Selected bond lengths (Å): Ir–C1 
2.051(3), Ir–N2 2.116(3), Ir–Cl 2.4274(9), Ir–Cp(centroid) 1.8189(16), C8–C9 1.391(5), C9–C10 1.374(5), C10–
C11 1.397(6), C11–C11 1.353(6), N2–C8 1.370(4), C8–N1 1.370(4), C12–N1 1.363(4). Selected bond angles 
(deg): C1–Ir–N1 77.40(12), C1–Ir–Cl 85.67(8), N2–Ir–Cl 87.33(8). The twisted out of plane distortion of the PYA 
ligand is clearly visible (dihedral angle C7–N2–C8–N1 60.40(4)°). 
 
Electrochemical analysis (CV) revealed a reversible oxidation potential at E1/2 = +0.69 
and +0.55 V vs SCE for complexes 16a and 16b, respectively. The potentials are moderately 
lower by 30 and 10 mV when compared to the potentials of the corresponding complexes 
without methoxy substituents (E1/2 = +0.72 for complex 12a and +0.56 V for 12b). A similar 
lowering of the oxidation potential by 30 mV was observed upon introduction of three MeO 
groups in the para-PYA complex 1 (E1/2 = +0.64 V, vs +0.61 V for 5).33 
  
Table 3. Catalytic water oxidation with complex 16a and 16b.a) 
Entry Complex conc. [µM] CAN/complex TON TOFmax (h–1) 
1 16a 49.9 7360 1810±30 1600±400 
2 16a 19.9 18440 4590±30 1160±80 
3 16b 49.9 7360 1810±40 1500±400 
4 16b 19.9 18440 4600±70 1210±60 
a) Measurements were performed in a sealed 40 mL EPA vial containing 10 mL 0.4M CAN solution buffered in 
1M HNO3 and the appropriate complex. O2 evolution was dynamically monitored with digital manometry and end 
points were calibrated by gas chromatography; TOFmax values were determined by calculating the rate of change 
of the generated oxygen over time from the kinetic trace.  
 
Even though each of the two structural features employed in the ligand design of 
complexes 16a and 16b, viz the three methoxy substituents on the cyclometalating phenyl group 
(cf complex 5) and the variation of the PYA ligands (cf complexes 12a and 12b), individually 
improved water oxidation, the water oxidation activity of complexes 16a and 16b is much more 
aligned with the performance of the parent complex 1, and no improved performance was 
	 17	
observed (Table 3). The activity of both 16a and 16b is less than that of the methoxy-free 
homologues 12a and 12b (e.g. for complex 16a, TOFmax at 50 µM catalyst concentration is 
1600 h–1 vs 1800 h–1 for 12a) and substantially lower than that of the (MeO)3-substituted para-
PYA analogue 5 (TOFmax = 3200 h–1 under identical conditions). Similarly, complex 16b 
reaches a TOFmax = 1500 h–1 at 50 µM iridium concentration, which is also lower than complex 
12b without methoxy groups (TOFmax = 1700 h–1).  
Structural analysis of the aqua intermediate by DFT (B3LYP/LANL2DZ) calculations 
offered two possible explanations for the underperformance of these two complexes, namely 
lower stability of the complex and lower accessibility of the catalytically active site. First, 
moving the pyridinium site from the isolated 4-position to the more crowded parts of the 
molecule increased the steric energy of the complexes significantly. The calculated heat of 
formation for the meta-PYA complex 16b is 6.2 kcal mol–1 higher, while the ortho- regioisomer 
16a has a 7.6 kcal mol–1 higher energy than the most stable complex 5. Second, the steric effects 
observed in the more congested isomers cause substantial twisting of the PYA ligand that is 
amplified by the three added methoxy groups. While the increase in steric energy might lead to 
an easier degradation of the two more congested complexes during catalysis, it is also evident 
that access to the active site is hindered by the twisted pyridinium ring. Figure 9 highlights this 
effect with a space-filling model of the two regioisomers 5 and 16a containing a substrate water 
molecule bound to iridium rather than a chloride. At a certain point on the catalytic cycle, water 
has to attack the oxygen of the active site to form an O–O bond.3b This attack is partially 
hindered by the congestion and the ensuing twisting of the ligand in complex 16a (dashed green 
arrow), and this reduced access will decrease water oxidation rates of this catalyst. In contrast, 
access to the iridium-bound ligand is much less restricted in complex 5 (solid green arrow).34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. DFT calculations (B3LYP/LANL2DZ) were used to produce optimized structures of the para-PYA 
complex 5 and the regioisomeric ortho-PYA complex 16a. The access to the active site required to form a O–O 
5 16ba
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bond is hindered by the twisted pyridinium ring (dashed arrow, arrow head pointing to coordinated water 
molecule), which leads to a decrease in reaction rates in 16a and 16b when compared with the isomeric champion 
catalyst 5 (compare accessibility of iridium (light blue) and coordinated water molecule as indicated by solid 
arrow). The increased steric energy of 16a and 16b might also lead to a more rapid degradation of these two 
catalysts. 
 
 
Conclusions 
We have successfully exploited the synthetic versatility of PYA ligands to prepare and evaluate 
a diverging series of iridium complexes containing chelating aryl-PYA ligands for water 
oxidation catalysis. Simple modifications, either by incorporating long aliphatic chains, or 
through electronic modulation by introducing electron-donating methoxy substituents on the 
aryl ring, or by altering the PYA positions (ortho-, meta-, para-PYA), were evaluated to 
optimize iridium-catalyzed water oxidation. While the incorporation of long alkyl chains had 
no significant effect, electronic modulation was effective and led to a substantial enhancement 
of catalytic activity and doubled the catalytic activity of the original lead compound to a TOFmax 
= 3300 h–1. This rate is substantially faster than most of the iridium-based water oxidation 
catalysts (typically 1000–1800 h–1), but lower than the fastest triazolylidene or pyridyl-
carboxylate catalysts (TOFmax 7,000–15,000 h–1). Even though optimization of the aryl and the 
PYA domains of the aryl-PYA chelate each led to improved catalysis, merging of the two 
optimized motifs in a single new aryl-PYA ligand failed to improve catalytic activity. 
Computational insights suggest an over-congestion at the active site, which hinders catalytic 
turnover. Moreover, these results indicate that optimization of the second coordination sphere 
provides an effective approach for further enhancing the catalytic activity of the metal center, 
particularly through introduction of advantageous hydrogen bonding sites. These results 
illustrate the complexity of ligand design and the subtle effects at play in catalytic reactions, 
and they emphasize the high versatility of the PYA platform for optimizing catalytic activity. 
Finally, it is worth noting that the electrochemical analysis of the catalyst precursors showed 
no correlation with catalytic activity. Since the stringent structure-activity relationship observed 
in this series of complexes is consistent with a molecularly defined catalytically active site, 
different mechanisms such as redox potentials of the pre-activated species appear to be relevant 
for facilitating catalytic turnover. Such mechanisms are not necessarily correlated to properties 
of the catalyst precursor, as demonstrated here with the electrochemical data. 
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Experimental 
 
General. The metal precursor salt [Ir(Cp*)Cl2]2
35 and complexes 1,18 2–5,19 and compounds 
9,26 14b–16b25 were all synthesized as reported in the literature. All other reagents were 
commercially available and used as received. Unless specified otherwise, NMR spectra were 
recorded at 25 °C on Bruker spectrometers operating at 300 or 400 MHz (1H NMR), and 100 
MHz (13C NMR), respectively. Chemical shifts (δ in ppm, coupling constants J in Hz) were 
referenced to residual solvent signals (1H, 13C). Assignments are based on homo- and 
heteronuclear shift correlation spectroscopy. Purity of bulk samples of the complexes has been 
established by NMR spectroscopy, and by elemental analysis, which were performed at the 
University of Bern Microanalytic Laboratory using a Thermo Scientific Flash 2000 CHNS-O 
elemental analyser. Residual solvent was confirmed by NMR spectroscopy and also by X–ray 
structure determinations. High-resolution mass spectrometry was carried out with a Thermo 
Scientific LTQ Orbitrap XL (ESI-TOF). 
 
Electrochemistry. Electrochemical measurements were carried out using an EG&G Princeton 
Applied Research potentiostat model 273A typically at a 100 mV s–1 sweep rate employing a 
gastight three-electrode cell under an argon atmosphere. A Pt disk with a 3.80 mm2 surface area 
was used as the working electrode and was polished before each measurement. The reference 
electrode was a Ag/AgCl electrode; the counter electrode was a Pt wire. Bu4NPF6 (0.1 M) in 
dry CH2Cl2 was used as a base electrolyte with analyte concentrations of approximately 10–3 
M. The ferrocenium/ferrocene redox couple was used as an internal reference (E1/2 = +0.46 V 
vs SCE in CH2Cl2).36 
 
 
General procedure for amide formation (9a, 9b, and 13b). A solution of the acyl chloride 
(11 mmol) in THF (10 mL) was added dropwise to a solution of aminopyridine (0.940 g, 10 
mmol) and NEt3 (1.50 mL, 11 mmol) in THF (30 mL), which resulted in the formation of a 
white suspension. The reaction was refluxed for 48 h. After cooling to rt, the solids were 
removed by filtration and washed with THF (50 mL). The filtrates were combined and all 
volatiles were removed in vacuo to leave a white solid, which was purified by column 
chromatography (SiO2; CH2Cl2/MeOH 95:5). All solvents were removed to yield the 
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corresponding amide as a white solid. Analytical data of these compounds are in agreement 
with those reported.37,38 
 
I. General procedure for the formation of pyridinium salts (6a–c, 10a,b and 14a). N-
(pyridin-4-yl)benzamide, 9a,b or 13a (2.0 mmol) was dissolved in MeCN (15 mL) in a pressure 
tube. The alkylating agent RI (R =iPr, nBu or Oct, 3.0 mmol) was added and the reaction was 
stirred for 18 h at 80 °C. The solution was cooled to rt and concentrated to 5 mL. Et2O (50 mL) 
was added affording compound as 6a–c, 10a,b and 14a a yellow solid, which was collected by 
filtration. 
 
II. General procedure for synthesis of the pyridylidene amides (7a–c, 11a,b and 15a). A 
suspension of the pyridinium salt 6a–c, 10a,b or 14a (1.0 mmol) in CH2Cl2 (10 mL) was placed 
into a separating funnel. Aqueous NaOH (15 mL, 2M) was added. After vigorous mixing, the 
organic phase was collected. The aqueous layer was extracted with CH2Cl2 (3 x 15 mL), the 
combined organic layers were dried over anhydrous Na2SO4 and filtered. All volatiles were 
removed, thus giving free ligand 7a–c, and 15a as white-yellow solids, which were purified by 
recrystallization from pentane and 11a,b as yellow oils. 
 
III. General procedure for the synthesis of iridium complexes (8a–c, 12a,b and 16a). 
Compound 7a–c, 11a,b or 15a (0.4 mmol), NaOAc (33 mg, 0.4 mmol) and [Ir(Cp*)Cl2]2 (120 
mg, 0.15 mmol) were dissolved in CH2Cl2 and stirred at rt for 18h. All volatiles were removed 
under reduced pressure and the crude solid was purified by column chromatography (SiO2; 
CH2Cl2/MeOH 98:2), thus yielding 8a–c, 12a.b and 16a as orange solids. 
 
Compound 6a 
Compound 6a was prepared according to the general procedure I from N-(pyridin-4-
yl)benzamide, (396 mg, 2.0 mmol) and iPrI (294 µL, 3.0 mmol). Yield: 690 mg, 94%. 
1H NMR (300 MHz, d6-DMSO): δ 11.54 (s, 1H, NH), 8.98 (d, 3JHH = 6.4 Hz, 2H, CHpyr), 8.31 
(d, 3JHH = 6.4 Hz, 2H, CHpyr), 8.03 (d, 2H, 3JHH = 7.6, CHPh), 7.72 (t, 1H, 3JHH = 7.6 Hz, 4JHH = 
1.3 Hz, CHPh), 7.63 (t, 2H, 3JHH = 7.6 Hz, CHPh), 4.88 (septet, 1H, 3JHH = 6.8 Hz, CHMe2), 1.57 
(d, 6H, 3JHH = 6.8 Hz, C–CH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 167.7 (CO), 152.4 
(Cpyr), 143.3 (CHpyr), 133.3 (CHPh), 132.9 (CPh), 128.8 (CHPh), 128.3 (CHPh), 115.9 (CHpyr), 
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62.2 (CHMe2), 22.3 (C–CH3). HR-MS: m/z calculated for C15H17N2O [M–I]+ = 241.1341; 
found, 241.1329.  
 
Compound 6b 
Compound 6b was prepared according to the general procedure I from N-(pyridin-4-
yl)benzamide, (396 mg, 2.0 mmol) and nBuI (341 µL, 3.0 mmol). Yield: 728 mg, 95%. 
1H NMR (400 MHz, d6-DMSO): δ 11.55 (s, 1H, NH), 8.88 (d, 3JHH = 7.3 Hz, 2H, CHpyr), 8.31 
(d, 3JHH = 7.3 Hz, 2H, CHpyr), 8.11–7.96 (m, 2H, CHPh), 7.75–7.68 (m, 1H, CHPh), 7.64–7.60 
(m, 2H, CHPh), 4.47 (t, 3JHH = 7.4 Hz, 2H, NCH2), 1.86 (quint, 3JHH = 7.4 Hz, 2H, NCH2CH2), 
1.29 (sext, 3JHH = 7.4 Hz, 2H, CH2CH3), 0.92 (t, 3JHH = 7.4 Hz, 3H, CH3). 13C{1H} NMR (100 
MHz, d6-DMSO): δ 167.2 (CO), 152.0 (Cpyr), 145.0 (CHpyr), 133.2 (CHPh), 132.9 (CPh), 128.8 
(CHPh), 128.3 (CHPh), 115.7 (CHpyr), 58.9 (NCH2), 32.3 (NCH2CH2), 18.7 (CH2CH3), 13.3 
(CH3). HR-MS: m/z calculated for C16H19N2O [M–I]+ = 255.1492; found 255.1489. Elem. 
Anal. Calcd. for C15H19IN2O: C, 50.28; H, 5.01; N, 7.33; Found: C, 50.31; H, 5.29; N, 7.53%. 
 
Compound 6c 
Compound 6c was prepared according to the general procedure I from N-(pyridin-4-
yl)benzamide, (396 mg, 2.0 mmol) and nOctI (541 µL, 3.0 mmol). Yield: 799 mg, 91%. 
1H NMR (400 MHz, d6-DMSO): δ 11.55 (s, 1H, NH), 8.85 (d, 3JHH = 7.4 Hz, 2H, CHpyr), 8.28 
(d, 3JHH = 7.4 Hz, 2H, CHpyr), 8.11–8.00 (m, 2H, CHPh), 7.78–7.67 (m, 1H, CHPh), 7.64–7.59 
(m, 2H, CHPh), 4.44 (t, 3JHH = 7.2 Hz, 2H, NCH2), 1.86 (quint, 3JHH = 7.2 Hz, 2H, NCH2CH2), 
1.31–1.21 (m, 10H, CH2), 0.86 (t, 3JHH = 7.0 Hz, 3H, CH3). 13C{1H} NMR (100 MHz, d6-
DMSO): δ 167.4 (CO), 152.5 (Cpyr), 144.9 (CHpyr), 133.1 (CHPh), 133.1 (CPh), 128.7 (CHPh), 
128.3 (CHPh), 115.8 (CHpyr), 59.1 (NCH2), 31.1 (NCH2CH2), 30.3, 28.4, 28.3, 25.3, 22.0 (5 ´ 
CH2), 13.9 (CH3). HR-MS: m/z calculated for C20H27N2O [M–I]+ = 311.2118; found; 311.2111. 
Elem. Anal. Calcd. For C20H27IN2O C, 54.80; H, 6.21; N, 6.39; Found: C, 54.83; H, 6.97; N, 
6.37%. 
 
Compound 7a 
Compound 7a was obtained as a white solid following the general procedure II from compound 
6a (368 mg, 1.0 mmol). Yield: 175 mg, 73%. 
1H NMR (300 MHz, d6-DMSO): δ 8.13 (d, 3JHH = 6.0 Hz, 2H, CHpyr), 8.12 (d, 3JHH = 7.3 Hz, 
2H, CHPh), 7.47 (d, 3JHH = 6.0 Hz, 2H, CHpyr), 7.42 (t, 1H, 3JHH = 7.3, CHPh), 7.38 (t, 2H, 3JHH 
= 7.3, CHPh 4.45 (septet, 1H, 3JHH = 6.8, CHMe2), 1.44 (d, 6H, 3JHH = 6.8, C–CH3). 13C{1H} 
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NMR (100 MHz, d6-DMSO): δ 173.9 (CO), 164.6 (Cpyr), 139.8 (CPh), 138.9 (CHpyr), 130.1 
(CHPh), 128.7 (CHPh), 127.6 (CHPh), 117.9 (CHpyr), 58.7 (CHMe2), 22.2 (C–CH3). HRMS: m/z 
calculated for C15H17N2O [M+H]+ = 241.1335; found, 241.1328. Elem. Anal. Calcd. for 
C15H16N2O: C, 74.97; H, 6.71; N, 11.66; Found: C, 74.29; H, 6.22; N, 11.85%. 
 
Compound 7b 
Compound 7b was obtained as a white solid following the general procedure II from compound 
6b (382 mg, 1.0 mmol). Yield: 219 mg, 84%. 
1H NMR (400 MHz, d6-DMSO): δ 8.17–8.08 (m, 2H, CHPh), 8.02 (d, 2H, 3JHH = 7.4, CHpyr), 
7.46 (d, 3JHH = 7.4 Hz, 2H, CHpyr), 7.43–7.34 (m, 3H, CHPh) 4.05 (t, 3JHH = 7.4 Hz, 2H, NCH2), 
1.73 (quint, 3JHH = 7.4 Hz, 2H, NCH2CH2), 1.26 (sext, 3JHH = 7.4 Hz, 2H CH2CH3), 0.90 (d, 
3JHH = 7.4 Hz, 3H, CH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 173.8 (CO), 164.2 (Cpyr), 
140.9 (CHpyr), 139.7 (CPh), 130.1 (CHPh), 128.7 (CHPh), 127.5 (CHPh), 117.7 (CHpyr), 56.2 
(NCH2), 32.3 (NCH2CH2), 18.8 (CH2CH3), 13.4 (CH3). HR-MS: m/z calculated for C16H19N2O 
[M+H]+ = 255.1492; found; 255.1485. Elem. Anal. Calcd. for C16H18N2O: C, 75.56; H, 7.13; 
N, 11.01; Found: C, 75.34; H, 7.02; N, 11.01%. 
 
Compound 7c 
Compound 7c was obtained as white solid following the general procedure II from compound 
6c (438 mg, 1.0 mmol). Yield: 239 mg, 77%. 
1H NMR (400 MHz, d6-DMSO): δ 8.23–8.08 (m, 2H, CHPh), 8.02 (d, 2H, 3JHH = 7.4, CHpyr), 
7.45 (d, 3JHH = 7.4 Hz, 2H, CHpyr), 7.43–7.34 (m, 3H, CHPh) 4.04 (t, 3JHH = 7.2 Hz, 2H, NCH2), 
1.74 (quint, 3JHH = 7.2 Hz, 2H, NCH2CH2), 1.32–1.18 (m, 10H, CH2), 0.85 (d, 3JHH = 6.8 Hz, 
3H, CH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 173.9 (CO), 164.3 (Cpyr), 140.9 (CHpyr), 
139.8 (CPh), 130.1 (CHPh), 128.7 (CHPh), 127.5 (CHPh), 117.7 (CHpyr), 56.5 (NCH2), 31.1 
(NCH2CH2), 30.3, 28.5, 28.4, 25.5, 22.0 (5 ´ CH2), 13.9 (CH3). HR-MS: m/z calculated for 
C15H18N2O [M+H]+ = 311.2118; found; 311.2114. Elem. Anal. Calcd. for C16H18N2O: C, 77.38; 
H, 8.44; N, 9.02; Found: C, 76.96; H, 8.40; N, 9.14%.  
 
Compound 8a 
Compound 8a was prepared according to the general procedure III from 7a (96 mg, 0.40 mmol) 
to give an orange solid. Yield: 98 mg, 54%. 
1H NMR (500 MHz, CDCl3): δ 8.54 (d, 3JHH = 6.9 Hz, 2H, CHpyr), 7.69 (d, 3JHH = 7.4 Hz, 1H, 
CHPh), 7.67 (d, 3JHH = 6.9 Hz, 2H, CHpyr), 7.57 (d, 3JHH = 7.4 Hz, H, CHPh) 7.21 (t, 3JHH = 7.4 
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Hz, 1H, CHPh), 6.93 (t, 3JHH = 7.4 Hz, 1H, CHPh), 4.27 (septett, 3JHH = 7.0 Hz, 1H, CHMe2), 
1.54 (s, 15H, Cp–CH3), 1.43 (d, 3JHH = 6.3 Hz, CH–CH3). 13C{1H} NMR (125 MHz, CDCl3): 
δ 181.1 (CO), 162.4 (Cpyr), 159.4 (CPh–Ir), 140.9 (CPh), 137.4 (CHpyr), 136.2 (CHPh), 132.3 
(CHPh), 127.9 (CHPh), 122.1 (CHPh), 121.1 (CHpyr), 87.3 (CCp), 60.0 (NCHMe2), 23.0 (CH–
CH3), 9.2 (Cp–CH3). HR-MS: m/z calculated for C25H30IrN2O [M–Cl]+ = 567.1988; found, 
567.1976. Elem Anal. Calcd. for C25H30ClIrN2O x 0.5 CH2Cl2: C, 47.51; H, 4.85; N, 4.35; 
Found C, 47.99; H, 4.76; N, 4.31. 
 
Compound 8b 
Compound 8b was prepared according to the general procedure III from 7b (102 mg, 0.40 
mmol) to give an orange solid. Yield: 110 mg, 76%. 
1H NMR (400 MHz, CDCl3): δ 8.31 (d, 3JHH = 7.0 Hz, 2H, CHpyr), 7.72 (dd, 3JHH = 7.6 Hz, 4JHH 
= 1.1 Hz 1H, CHPh), 7.61–7.52 (m, 3H, CHpyr + CHPh), 7.22 (td, 3JHH = 7.3 Hz, 4JHH = 1.5 Hz, 
1H, CHPh), 6.95 (td, 3JHH = 7.3 Hz, 4JHH = 1.1 Hz, 1H, CHPh), 3.81–3.52 (m, 2H, NCH2), 1.51–
1.41 (m, 2H, NCH2CH2), 1.46 (s, 15H, Cp–CH3), 1.11–0.93 (m, 2H, CH2CH3), 0.75 (t, 3JHH = 
7.3 Hz, 2H, CH2CH3). 13C{1H} NMR (100 MHz, CDCl3): δ 183.3 (CO), 162.4 (Cpyr), 159.6 
(CPh–Ir), 141.2 (CPh), 140.3 (CHpyr), 136.3 (CHPh), 132.2 (CHPh), 127.8 (CHPh), 122.1 (CHPh), 
121.2 (CHpyr), 87.2 (CCp), 58.3 (NCH2), 32.2 (NCH2CH2), 19.2 (CH2CH3), 13.5 (CH2CH3), 9.1 
(Cp–CH3). HR-MS: m/z calculated for C26H32IrN2O [M–Cl]+ = 581.2144; found, 581.2125. 
Elem Anal. Calcd. for C26H32ClIrN2O: C, 50.68; H, 5.23; N, 4.55; Found: C, 50.12; H, 4.98; N, 
4.53%. 
 
Compound 8c 
Compound 8c was prepared according to the general procedure III from 7c (124 mg, 0.40 
mmol) to give an orange solid. Yield: 120 mg, 75%. 
1H NMR (400 MHz, CDCl3): δ 8.30 (d, 3JHH = 7.1 Hz, 2H, CHpyr), 7.71 (dd, 3JHH = 7.5 Hz, 4JHH 
= 1.0 Hz 1H, CHPh), 7.62–7.56 (m, 1H, CHPh), 7.57 (d, 3JHH = 7.1 Hz, 2H, CHpyr), 7.21 (td, 3JHH 
= 7.3 Hz, 4JHH = 1.5 Hz, 1H, CHPh), 6.94 (td, 3JHH = 7.3 Hz, 4JHH = 1.3 Hz, 1H, CHPh), 3.72–
3.53 (m, 2H, NCH2), 1.45 (s, 15H, Cp–CH3),1.44–1.39 (m, 2H, NCH2CH2), 1.30–1.21 (m, 2H, 
CH2), 1.19–1.08 (m, 6H, CH2), 0.96–0.86 (m, 2H, CH2), 0.86 (t, 3JHH = 7.1 Hz, 3H, CH2CH3). 
13C{1H} NMR (100 MHz, CDCl3): δ 183.2 (CO), 162.5 (Cpyr), 159.6 (CPh–Ir), 141.2 (CPh), 
140.4 (CHpyr), 136.3 (CHPh), 132.2 (CHPh), 127.7 (CHPh), 122.1 (CHPh), 121.2 (CHpyr), 87.2 
(CCp), 58.6 (NCH2), 31.7 (NCH2CH2), 31.2, 29.1, 28.9, 25.9, 22.7 (5 ´ CH2), 14.2 (CH2CH3), 
9.1 (Cp–CH3). HR-MS: m/z calculated for C30H40IrN2O [M–Cl]+ = 637.2770; found, 637.2739. 
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Elem Anal. Calcd. for C30H40ClIrN2O ´ 0.5 CH2Cl2: C, 51.15; H, 5.43; N, 3.92; Found: C, 
50.58; H, 5.43; N, 3.84%. 
 
Compound 10a 
Compound 10a was prepared according to the general procedure I from 9a (396 mg, 2.0 mmol) 
and MeI (187 µL, 3.0 mmol): Yield 251 mg, 39%. 
1H NMR (400 MHz, d6-DMSO): δ 11.40 (s, 1H, NH), 8.95 (d, 3JHH = 6.3, Hz, 1H, CHpyr), 8.58 
(t, 3JHH = 8.1, 4JHH = 1.4 Hz, 1H, CHpyr), 8.22 (dd, 3JHH = 8.1, 4JHH = 1.4 Hz, 1H, CHpyr), 8.11–
8.01 (m, 2H, CHPh), 7.89 (t, 3JHH = 6.3 Hz, 1H, CHpyr), 7.75–7.68 (m, 1H, CHPh), 7.65–7.59 (m, 
2H, CHPh), 4.29 (s, 3H, NCH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 166.6 (CO), 148.1 
(Cpyr), 146.0 (CHpyr), 145.6 (CHpyr), 133.2 (CHPh), 132.5 (CPh), 128.7 (CHPh), 128.6 (CHPh), 
124.1 (CHpyr), 123.2 (CHpyr), 44.3 (NCH3). HR-MS: m/z calculated for C13H13N2O [M–I]+ = 
213.1022; found, 213.1025. Elem. Anal. Calcd. For for C13H13IN2O ´ 0.5 H2O: C, 44.72; H, 
4.04; N, 8.02; Found: C, 44.43; H, 3.90; N, 7.98%. 
 
Compound 10b 
Compound 10b was prepared according to the general procedure I from 9b (396 mg, 2.0 mmol) 
and MeI (187 µL, 3.0 mmol): Yield 646 mg, 95%. 
1H NMR (400 MHz, d6-DMSO): δ 11.17 (s, 1H, NH), 9.52 (s, 1H, CHpyr), 8.76 (d, 3JHH = 5.9, 
Hz 1H, CHpyr), 8.65 (d, 3JHH = 8.8 Hz, 1H, CHpyr), 8.14 (dd, 3JHH = 8.8, 5.9 Hz, 1H, CHpyr), 
8.05–7.99 (m, 2H, CHPh), 7.73–7.66 (m, 1H, CHPh), 7.64–7.57 (m, 2H, CHPh), 4.41 (s, 3H, 
NCH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 166.3 (CO), 140.3 (Cpyr), 139.0 (CHpyr), 136.3 
(CHpyr), 134.6 (CHpyr), 133.0 (CPh), 132.8 (CHPh), 128.5 (CHPh), 127.9 (CHPh), 127.8 (CHpyr), 
48.6 (NCH3). HR-MS: m/z calculated for C13H13N2O [M–I]+ = 213.1022; found, 213.1032. 
 
Compound 11a 
Compound 11a was obtained as pale yellow oil following the general procedure II from 
compound 10a (320 mg, 1.0 mmol). Yield: 174 mg, 82%. 
1H NMR (400 MHz, d6-DMSO): δ 8.31 (d, 3JHH = 8.9, Hz, 1H, CHpyr), 8.21–8.17 (m, 2H, CHPh), 
8.17–8.13 (m, 1H, CHpyr), 7.74 (ddd, 3JHH = 8.1, 6.7, 4JHH = 1.5 Hz 1H, CHpyr), 7.49–7.36 (m, 
3H, CHPh), 6.73 (td, 3JHH = 6.7, 4JHH = 1.5 Hz, 1H, CHpyr), 3.87 (s, 3H, NCH3). 13C{1H} NMR 
(100 MHz, d6-DMSO): δ 172.0 (CO), 158.4 (Cpyr), 141.0 (CHpyr), 140.1 (CHpyr), 139.4 (CPh), 
130.5 (CHPh), 128.8 (CHPh), 127.7 (CHPh), 119.2 (CHpyr), 111.2 (CHpyr), 41.0 (NCH3). HR-MS: 
m/z calculated for C13H13N2O [M+H]+ = 213.1022; found, 213.1022. 
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Compound 11b 
Compound 11b was obtained as pale yellow oil following the general procedure II from 
compound 10b (320 mg, 1.0 mmol). Yield: 145 mg, 68%. 
1H NMR (400 MHz, d6-DMSO): δ 9.22 (s, 1H, CHpyr), 8.32 (d, 3JHH = 9.0 Hz, 1H, CHpyr), 8.20–
8.09 (m, 2H, CHPh), 8.02 (d, 3JHH = 5.8 Hz, 1H, CHpyr), 7.66 (dd, 3JHH = 9.0, 5.8 Hz, 1H, CHpyr), 
7.30–7.26 (m, 3H, CHPh), 4.20 (s, 3H, NCH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 170.5 
(CO), 153.8 (Cpyr), 141.2 (CPh), 138.6 (CHpyr), 136.4 (CHpyr), 131.6 (CHpyr), 128.9 (CHPh), 
128.2 (CHPh), 127.2 (CHPh), 126.3 (CHpyr), 47.3 (NCH3). HR-MS: m/z calculated for 
C13H13N2O [M+H]+ = 213.1022; found, 213.1030. 
 
Compound 12a 
Compound 12a was prepared according to the general procedure III from 11a (85 mg, 0.40 
mmol) to give an orange solid. Yield: 124 mg, 72%. 
1H NMR (400 MHz, CD2Cl2): δ 8.74 (bs, 1H, CHpyr), 8.08–7.94 (m, 2H, CHpyr), 7.72 (d, 3JHH 
= 7.5 Hz, 1H, CHPh), 7.54 (dd, 3JHH =7.5, 4JHH = 1.6 Hz, 1H, CHPh), 7.25–7.15 (m, 1H, CHpyr), 
7.25–7.15 (m, 1H, CHPh), 6.96 (td, 3JHH = 7.3, 4JHH = 1.2 Hz, 1H, CHPh), 3.96 (s, 3H, NCH3), 
1.46 (s, 15H, Cp–CH3). 13C{1H} NMR (100 MHz, CD2Cl2): δ 179.6 (CO), 162.2 (Cpyr), 158.6 
(CPh–Ir), 142.8 (CHpyr), 141.1 (CHpyr), 140.4 (CPh), 136.3 (CHPh), 131.8 (CHPh), 129.1 (CHpyr), 
128.6 (CHPh), 121.1 (CHPh), 119.6 (CHpyr), 87.5 (CCp), 44.9 (NCH3), 9.4 (Cp–CH3). HR-MS: 
m/z calculated for C23H26IrN2O [M–Cl]+ = 539.1669; found, 539.1665. Elem. Anal. Calcd. For 
C23H26ClIrN2O: C, 48.12; H, 4.56; N, 4.88; Found: C, 47.37; H, 4.30; N, 4.69. 
 
Compound 12b 
Compound 12b was prepared according to the general procedure III from 11b (85 mg, 0.40 
mmol) to give an orange solid. Yield: 117 mg, 68%. 
1H NMR (400 MHz, CD2Cl2): δ 9.65 (s, 1H, CHpyr), 9.00 (d, 3JHH = 8.7 Hz, 1H, CHpyr), 7.70 
(d, 3JHH = 7.6 Hz, 1H, CHPh), 7.67 (d, 3JHH = 5.9 Hz, 1H, CHpyr), 7.55–7.45 (m, 2H, CHPh + 
CHpyr), 7.17 (td, 3JHH = 7.6, 4JHH = 1.5 Hz, 1H, CHPh), 6.93 (t, 3JHH = 7.6 Hz, 1H, CHPh), 4.12 
(s, 3H, NCH3), 1.47 (s, 15H, Cp–CH3). 13C{1H} NMR (100 MHz, CD2Cl2): δ 181.1 (CO), 
158.7 (CPh–Ir), 152.9 (Cpyr), 141.8 (CPh), 141.6 (CHpyr), 141.0 (CHpyr), 136.3 (CHPh), 133.3 
(CHpyr), 131.6 (CHPh), 127.9 (CHpyr), 126.9 (CHPh), 121.9 (CHPh), 87.3 (CCp), 48.8 (NCH3), 
9.4 (Cp–CH3). HR-MS: m/z calculated for C23H26IrN2O [M–Cl]+ = 539.1669; found, 
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539.1684. Elem. Anal. Calcd. For C23H26ClIrN2O x 0.2 CH2Cl2: C, 47.14; H, 4.50; N, 4.74; 
Found: C, 46.96; H, 4.31; N, 4.57%.  
 
Compound 14a 
Compound 14a was prepared according to the general procedure I from 13a (576 mg, 2.0 mmol) 
and MeI (187 µL, 3.0 mmol): Yield 500 mg, 58%. 
1H NMR (300 MHz, CD3CN): δ 10.32 (s, 1H, NH), 8.63 (dd, 3JHH = 6.4, 4JHH = 1.7 Hz, CHpyr 
1H, CHpyr), 8.46 (td, 3JHH = 8.1, 4JHH = 1.7, 1H, CHpyr), 8.26 (dd, 3JHH = 7.7, 4JHH = 1.4 Hz, 1H, 
CHpyr), 7.77 (ddd, 3JHH = 8.1, 6.4, 4JHH = 1.4 Hz, 1H, CHpyr), 7.42 (s, 2H, CHPh), 4.30 (s, 3H, 
NCH3), 3.94 (s, 6H, OCH3), 3.79 (s, 3H, OCH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 166.3 
(CO), 153.9 (CPh), 148.8 (Cpyr), 146.9 (CHpyr), 146.1 (CHpyr), 142.6 (CPh), 127.5 (CPh), 125.9 
(CHpyr), 124.6 (CHpyr), 106.8 (CHPh), 60.7 (OCH3), 57.0 (OCH3), 46.2 (NCH3). Elem. Anal. 
Calcd. For C16H19IN2O4: C, 44.67; H, 4.45; N, 6.51; Found: C 44.29; H, 4.58; N, 6.30%. 
 
Compound 15a 
Compound 15a was obtained as pale yellow solid following the general procedure II from 
compound 14a (320 mg, 1.0 mmol). Yield: 241 mg, 80% 
1H NMR (400 MHz, d6-DMSO): δ 8.26 (d, 3JHH = 8.7 Hz, 1H, CHpyr), 8.15 (dd, 3JHH = 6.6, 
4JHH = 1.8 Hz, 1H, CHpyr), 7.73 (ddd, 3JHH = 8.7, 6.6, 4JHH = 1.8 Hz, 1H, CHpyr), 7.51 (s, 2H, 
CHPh), 6.72 (td, 3JHH = 6.6, 4JHH = 1.8 Hz, 1H, CHpyr), 3.87 (s, 3H, NCH3), 3.83 (s, 6H, 
OCH3), 3.71 (s, 3H, OCH3). 13C{1H} NMR (100 MHz, d6-DMSO): δ 171.4 (CO), 158.2 
(Cpyr), 152.1 (CPh), 141.0 (CHpyr), 140.0 (CHpyr), 139.8 (CPh), 134.9 (CPh), 119.0 (CHpyr), 
111.0 (CHpyr), 106.1 (CHPh), 60.0 (OCH3), 55.7 (OCH3), 41.0 (NCH3). HR-MS: m/z 
calculated for C16H19N2O4 [M+H]+ = 303.1339; found, 303.1338.  
 
Compound 16a 
Compound 16a was prepared according to the general procedure III from 15a (120 mg, 0.40 
mmol) to give an orange solid. Yield: 165 mg, 69%. 
1H NMR (400 MHz, CD2Cl2): δ 8.92 (bs, 1H, CHpyr), 8.01–7.90 (m, 2H, CHpyr), 7.20 (td, 3JHH 
= 6.9, 4JHH = 1.5 Hz, 1H, CHpyr), 7.08 (s, 1H, CHPh), 3.97 (s, 3H, NCH3), 3.93 (s, 3H, OCH3), 
3.83 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 1.46 (s, 15H, Cp–CH3). 13C{1H} NMR (100 MHz, d6-
DMSO): δ 178.8 (CO), 161.5 (Cpyr), 156.3 (CPh–Ir), 149.8 (CPh), 146.1 (CPh), 143.4 (CPh), 142.6 
(CHpyr), 140.5 (CHpyr), 134.6 (CPh), 128.6 (CHpyr), 119.5 (CHpyr), 108.4 (CHPh), 87.5 (CCp), 61.5 
(OCH3), 60.9 (OCH3), 56.1 (OCH3), 44.7 (NCH3), 9.5 (Cp–CH3). HR-MS: m/z calculated for 
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C26H32IrN2O4 [M–Cl]+ = 629.1991; found, 629.1974. Elem. Anal. Calcd. For C26H32ClIrN2O4: 
C, 47.02; H, 4.86; N, 4.22; Found: C, 46.94; H, 4.86; N, 4.13. 
 
 
Dynamic Oxygen Evolution Measurements. For oxygen evolution measurements, a solution 
of the iridium complex (1 mL) was injected into a sealed 40 mL EPA vial containing 10 mL 
CAN solution (~ 0.4 M) buffered in 1M HNO3. The generated oxygen lead to an increase in 
gas phase pressure, which was dynamically monitored via differential digital manometry as 
described previously.8 End points of the reactions were verified by gas chromatography and 
corrected for nitrogen contamination. 
 
DFT Calculations. All DFT calculations were performed with Gaussian 09 using B3LYP 
functional and LANL2DZ basis set. Default parameters and thresholds were used for gradient 
convergence. Geometry optimizations were carried out without additional constraints of solvent 
environment. The optimized geometries of the complexes were visualized with Avogadro.39 
 
Crystal structure determinations. Suitable crystals of 8b, 8c, 12b and 16a were mounted in 
air at ambient conditions and measured on an Oxford Diffraction SuperNova area-detector 
diffractometer
 
at T = 173(2) K using mirror optics monochromated Mo Kα radiation (λ = 
0.71073 Å) and Al filtered.40 Data reduction was performed using the CrysAlisPro program.41 
The intensities were corrected for Lorentz and polarization effects, and an absorption correction 
based on the multi-scan method using SCALE3 ABSPACK in CrysAlisPro was applied. The 
structures were solved by direct methods using SHELXT,42 and all non-hydrogen atoms were 
refined anisotropically. All H-atoms were placed in geometrically calculated positions and 
refined using a riding model with each H-atom assigned a fixed isotropic displacement 
parameter (1.2Ueq of its parent atom, 1.5Ueq for the methyl groups). Structures were refined 
on F2 using full-matrix least-squares procedures. The weighting schemes were based on 
counting statistics and included a factor to downweight the intense reflections. All calculations 
were performed using the SHELXL-2014 program.42 
The crystal of 8b contains two independent molecules of the metal complex in the asymmetric 
unit and one co-crystallized CH2Cl2 molecule. The liberation of the butyl chain of one of the 
two independent molecules was found to be quite large (probably affected by some dynamic 
disorder that could not be modelled properly). A restraint on the most external C–C bond 
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distance was applied as well as a limitation of the anisotropic displacement parameter for the 
two C atoms involved. The crystal of 8c contains two metal complex molecules and one co-
crystallized dichloromethane molecule in the asymmetric unit. Part of one octyl group is 
disordered over two conformations. The co-crystallized dichloromethane molecule is 
disordered over two sites. The geometries of the disordered moieties were restrained to be 
equal. Its ADP’s were restrained by the SHELXL SIMU and DELU instructions. The crystal 
12b contains two independent molecules of the complex in the asymmetric unit and co-
crystallized CH2Cl2 (one molecule in general position, one disordered about an inversion 
center). The crystal possesses pseudo-translational elements that would produce a C-1 type 
structure (equivalent to a P-1 with halved volume). This would imply that the two complexes 
are equivalent but their conformation clearly differ, especially in the Cp* group. Moreover, the 
position of the clathrated solvent about the inversion center makes the double unit cell the best 
suggestion (as also proved by the accurate analysis of the weaker reflections). A structure 
solved in C-1 gave clearly worse refinement indices (R1 = 3.37%, instead of 2.18% of the P-1 
solution) and larger atomic displacement parameters, especially for the Cp* atoms. Moreover, 
the pseudo C translation would be violated by half of the measured reflections. For compound 
16a, there are two solvent molecules in a crystal structure. Position of water molecule was 
refined without doubts, but the second one was assumed a CH2Cl2 molecule as it was used for 
crystallization. The molecule is highly disordered and no hydrogen atoms were assigned. 
Chlorine and carbon atoms were assigned according to the donor-acceptor adjacent of the 
molecule. Further details are given in Tables S2–S5. Crystallographic data for all four structures 
have been deposited with the Cambridge Crystallographic Data Centre (CCDC) as 
supplementary publication numbers 1585829 (8b), 1585830 (8c), 1585831 (12b), and 1585832 
(16a). 
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Pyridylidene-amide (PYA) ligands offer a versatile platform for synthetic modification and for 
tailoring catalytic activity, both by modulating the aryl substituent as well as by modifying the 
position of the pyridinium site from weakly donating to mesoionic PYA systems, and sterically 
congested 2-pyridylidene isomer, with profound impact on the catalytic activity of the iridium 
center in water oxidation.  
